Ile-Pro-Pro Attenuates Sympathetic Activity and Hypertension

Overview

Journal J Physiol Biochem

Specialties Biochemistry
Physiology

Date 2024 Jul 15

PMID 39008241

Authors

Jun-Liu Chen

Rui Ge

Xiu-Zhen Li

Yue Zhang

Wen-Yuan Hao

Na Li

Zhi-Qin Xu

Qi Chen

Yue-Hua Li

Guo-Qing Zhu

Xiao Tan

Affiliations

Soon will be listed here.

Abstract

Isoleucine-proline-proline (Ile-Pro-Pro, IPP) is a natural food source tripeptide that inhibits angiotensin-converting enzyme (ACE) activity. The aim of this study was to determine the central and peripheral roles of IPP in attenuating sympathetic activity, oxidative stress and hypertension. Male Sprague-Dawley rats were subjected to sham-operated surgery (Sham) or two-kidney one-clip (2K1C) surgery to induce renovascular hypertension. Renal sympathetic nerve activity and blood pressure were recorded. Bilateral microinjections of IPP to hypothalamic paraventricular nucleus (PVN) attenuated sympathetic activity (-16.1 ± 2.5%, P < 0.001) and hypertension (-8.7 ± 1.5 mmHg, P < 0.01) in 2K1C rats by inhibiting ACE activity and subsequent angiotensin II and superoxide production in the PVN. Intravenous injections of IPP also attenuated sympathetic activity (-15.1 ± 2.1%, P < 0.001) and hypertension (-16.8 ± 2.3 mmHg, P < 0.001) via inhibiting ACE activity and oxidative stress in both PVN and arteries of 2K1C rats. The duration of the effects of the intravenous IPP was longer than those of the PVN microinjection, but the sympatho-inhibitory effect of intravenous injections occurred later than that of the PVN microinjection. Intraperitoneal injection of IPP (400 pmol/day for 20 days) attenuated hypertension and vascular remodeling via inhibiting ACE activity and oxidative stress in both PVN and arteries of 2K1C rats. These results indicate that IPP attenuates hypertension and sympathetic activity by inhibiting ACE activity and oxidative stress. The sympathoinhibitory effect of peripheral IPP is mainly caused by the ACE inhibition in PVN, and the antihypertensive effect is related to the sympathoinhibition and the arterial ACE inhibition. Long-term intraperitoneal IPP therapy attenuates hypertension, oxidative stress and vascular remodeling.

References

Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T . Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci. 1995; 78(4):777-83. DOI: 10.3168/jds.S0022-0302(95)76689-9. View

Nourmohammadi E, Sadeghi Mahoonak A . Health Implications of Bioactive Peptides: A Review. Int J Vitam Nutr Res. 2019; 88(5-6):319-343. DOI: 10.1024/0300-9831/a000418. View

Li S, Bu T, Zheng J, Liu L, He G, Wu J . Preparation, Bioavailability, and Mechanism of Emerging Activities of Ile-Pro-Pro and Val-Pro-Pro. Compr Rev Food Sci Food Saf. 2020; 18(4):1097-1110. DOI: 10.1111/1541-4337.12457. View

Gregory K, Cozier G, Schwager S, Sturrock E, Acharya K . Structural insights into the inhibitory mechanism of angiotensin-I-converting enzyme by the lactotripeptides IPP and VPP. FEBS Lett. 2023; 598(2):242-251. PMC: 10952540. DOI: 10.1002/1873-3468.14768. View

Craft I, Geddes D, Hyde C, Wise I, Matthews D . Absorption and malabsorption of glycine and glycine peptides in man. Gut. 1968; 9(4):425-37. PMC: 1552714. DOI: 10.1136/gut.9.4.425. View

Vanhoof G, Goossens F, De Meester I, Hendriks D, Scharpe S . Proline motifs in peptides and their biological processing. FASEB J. 1995; 9(9):736-44. View

Iwasa M, Takezoe S, Kitaura N, Sutani T, Miyazaki H, Aoi W . A milk casein hydrolysate-derived peptide enhances glucose uptake through the AMP-activated protein kinase signalling pathway in skeletal muscle cells. Exp Physiol. 2020; 106(2):496-505. DOI: 10.1113/EP088770. View

van der Pijl P, Kies A, Ten Have G, Duchateau G, Deutz N . Pharmacokinetics of proline-rich tripeptides in the pig. Peptides. 2008; 29(12):2196-202. DOI: 10.1016/j.peptides.2008.08.011. View

Alcocer L, Bryce A, Brasil D, Lara J, Cortes J, Quesada D . The Pivotal Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertension Management and Cardiovascular and Renal Protection: A Critical Appraisal and Comparison of International Guidelines. Am J Cardiovasc Drugs. 2023; 23(6):663-682. PMC: 10625506. DOI: 10.1007/s40256-023-00605-5. View

10.

Grassi G, Mark A, Esler M . The sympathetic nervous system alterations in human hypertension. Circ Res. 2015; 116(6):976-90. PMC: 4367954. DOI: 10.1161/CIRCRESAHA.116.303604. View

11.

DeLalio L, Sved A, Stocker S . Sympathetic Nervous System Contributions to Hypertension: Updates and Therapeutic Relevance. Can J Cardiol. 2020; 36(5):712-720. PMC: 7534536. DOI: 10.1016/j.cjca.2020.03.003. View

12.

Dampney R, Michelini L, Li D, Pan H . Regulation of sympathetic vasomotor activity by the hypothalamic paraventricular nucleus in normotensive and hypertensive states. Am J Physiol Heart Circ Physiol. 2018; 315(5):H1200-H1214. PMC: 6297824. DOI: 10.1152/ajpheart.00216.2018. View

13.

Chen W, Xiong X, Chen Q, Li Y, Kang Y, Zhu G . Cardiac sympathetic afferent reflex and its implications for sympathetic activation in chronic heart failure and hypertension. Acta Physiol (Oxf). 2015; 213(4):778-94. DOI: 10.1111/apha.12447. View

14.

Chen A, Zhang S, Yuan N, Xu Y, De W, Gao X . Angiotensin AT1 receptors in paraventricular nucleus contribute to sympathetic activation and enhanced cardiac sympathetic afferent reflex in renovascular hypertensive rats. Exp Physiol. 2010; 96(2):94-103. DOI: 10.1113/expphysiol.2010.054353. View

15.

Ye C, Qiu Y, Zhang F, Chen A, Zhou H, Wang J . Chemical Stimulation of Renal Tissue Induces Sympathetic Activation and a Pressor Response via the Paraventricular Nucleus in Rats. Neurosci Bull. 2019; 36(2):143-152. PMC: 6977808. DOI: 10.1007/s12264-019-00417-1. View

16.

Fan Z, Zhang L, Shi Z, Gan X, Gao X, Zhu G . Artificial microRNA interference targeting AT(1a) receptors in paraventricular nucleus attenuates hypertension in rats. Gene Ther. 2011; 19(8):810-7. DOI: 10.1038/gt.2011.145. View

17.

Liu L, Zheng J, Zhou M, Li S, He G, Wu J . Peptide Analogues of VPP and IPP with Improved Glucose Uptake Activity in L6 Myotubes can be Released from Cereal Proteins. J Agric Food Chem. 2021; 69(9):2875-2883. DOI: 10.1021/acs.jafc.1c00587. View

18.

Zimmerman M . Angiotensin II and angiotensin-1-7 redox signaling in the central nervous system. Curr Opin Pharmacol. 2011; 11(2):138-43. PMC: 3075313. DOI: 10.1016/j.coph.2011.01.001. View

19.

Sipola M, Finckenberg P, Korpela R, Vapaatalo H, Nurminen M . Effect of long-term intake of milk products on blood pressure in hypertensive rats. J Dairy Res. 2002; 69(1):103-11. DOI: 10.1017/s002202990100526x. View

20.

Imamura A, Mackenzie H, Lacy E, Hutchison F, Fitzgibbon W, Ploth D . Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats. Kidney Int. 1995; 47(5):1394-402. DOI: 10.1038/ki.1995.196. View